Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Huntington's disease
Economic impact of Huntington's disease on families
9 evidence topics · 11 sources
Informal care and caregiver productivity costs: HDBOI study (2020 euros)
| Cost component | Early stage, mean (SD) and n | Mid stage, mean (SD) and n | Advanced stage, mean (SD) and n |
|---|---|---|---|
| Informal care | “€27,760 (€37,790) n = 121” | “€30,243 (€37,046) n = 120” | “€37,758 (€45,515) n = 83” |
| Lost productivity, caregiver | “€18,225 (€19,864) n = 33” | “€12,988 (€15,621) n = 46” | “€17,280 (€19,266) n = 49” |
| State support, caregiver | “€5134 (€5834) n = 22” | “€5897 (€5098) n = 36” | “€4778 (€3359) n = 43” |
Informal caregiver time and objective burden: France
Caregiver employment and work productivity: HDBOI caregivers
Caregivers of people with advanced HD in North America: systematic literature review
| Caregiver outcome | Quoted value |
|---|---|
| Mean time spent as primary carer (years) | “10.2 years” |
| Total hours of formal care per week | “43 hours” |
| Total hours of informal care per week | “41 hours” |
| Prevented career progression | “51%” |
| Prevented from working more hours | “70%” |
| Overall work productivity loss | “54%” |
Informal care as a share of societal cost: United Kingdom and Norway
Out-of-pocket financing by families: Peru
Juvenile-onset HD: costs to the NHS and to families (England and Wales, 2020 pounds)
| Severity | “No. accessing” | Costs to family, “Mean (SD)” |
|---|---|---|
| Mild | “9 (90%)” | “£19,269 (£17,995)” |
| Moderate | “7 (100%)” | “£33,118 (£45,657)” |
| Advanced | “14 (100%)” | “£48,696 (£55,825)” |
| All | “32 (97.0%)” | “£35,993 (£43,918)” |